A Pilot Study of Topical Honey for the Treatment of Psoriasis

Completed

• Conditions: Psoriasis; Skin - Dermatological conditions

• Registration Number: ACTRN12612000562875
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

Aged 16 or over at the time of enrolment
Psoriasis involving the upper or lower limbs
Bilateral lesions, to allow comparison

Exclusion Criteria

Requirement for topical or systemic corticosteroids, as judged by treating doctor
Requirement for antibiotic therapy, as judged by treating doctor
Known or suspected allergy to honey or dressings
Any other condition which, at the investigators discretion, it is believed may present a safety risk or impact the feasibility of the study or the study results

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Psoriasis severity assessed by intensity component of PASI (Psoriasis Area and Severity Index)[At baseline and at final visit after 2 weeks]

Secondary Outcome Measures

Name	Time	Method
Subjective assessment of lesion severity, measured by visual analogue score (VAS)[At baseline and at final visit after 2 weeks];Acceptability of honey therapy, measured by VAS[At final visit after 2 weeks]